Is ITCI or NOBL a better dividend investment in 2026?

ITCI currently yields 1.52% with a 5% 5-year dividend growth rate. NOBL yields 2.17% with 5% growth. The better choice depends on your goal: NOBL offers higher current income.

What is the dividend yield difference between ITCI and NOBL?

ITCI has a forward dividend yield of 1.52% ($2.00/share annually). NOBL yields 2.17% ($2.27/share annually). The yield gap is 0.65 percentage points.

Home › Compare › ITCI vs NOBL

ITCI vs NOBL: Dividend Comparison 2026

ITCI yields 1.52% · NOBL yields 2.17%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 NOBL wins by $1.0K in total portfolio value

INVESTMENT

TIME HORIZON10 years

ITCI

● Live price

1.52%

Share price

$131.87

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$21.9K

Annual income

$167.32

Full ITCI calculator →

NOBL

● Live price

2.17%

Share price

$104.67

Annual div

$2.27

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$22.9K

Annual income

$249.78

Full NOBL calculator →

Portfolio growth — ITCI vs NOBL

📍 NOBL pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ITCI	NOBL
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ITCI + NOBL cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ITCI pays

NOBL pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ITCI

Annual income on $10K today (after 15% tax)

$128.91/yr

After 10yr DRIP, annual income (after tax)

$142.22/yr

NOBL

Annual income on $10K today (after 15% tax)

$184.52/yr

After 10yr DRIP, annual income (after tax)

$212.31/yr

At 15% tax rate, NOBL beats the other by $70.09/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ITCI + NOBL for your $10,000?

ITCI: 50%NOBL: 50%

100% NOBL50/50100% ITCI

Portfolio after 10yr

$22.4K

Annual income

$208.55/yr

Blended yield

0.93%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on ITCI right now

ITCI

Analyst Ratings

Buy

Hold

Consensus: Buy

Price Target

$98.50

-25.3% upside vs current

Range: $70.00 — $132.00

Altman Z

38.0

Piotroski

2/9

NOBL

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ITCI buys

NOBL buys

No recent congressional trades found for ITCI or NOBL in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricITCINOBL

Forward yield	1.52%	2.17% ✓
Annual dividend / share	$2.00	$2.27 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$21.9K	$22.9K ✓
Annual income after 10y	$167.32	$249.78 ✓
Total dividends collected	$1.6K	$2.3K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: ITCI vs NOBL ($10,000, DRIP)

Year	ITCI Portfolio	ITCI Income/yr	NOBL Portfolio	NOBL Income/yr	Gap
1← crossover	$10,852	$151.66	$10,917	$217.08	$65.00 → NOBL
2	$11,765	$153.81	$11,903	$221.48	$138.00 → NOBL
3	$12,745	$155.85	$12,962	$225.68	$217.00 → NOBL
4	$13,794	$157.78	$14,099	$229.68	$305.00 → NOBL
5	$14,920	$159.61	$15,319	$233.49	$399.00 → NOBL
6	$16,125	$161.33	$16,628	$237.10	$503.00 → NOBL
7	$17,417	$162.96	$18,033	$240.53	$616.00 → NOBL
8	$18,801	$164.50	$19,539	$243.78	$738.00 → NOBL
9	$20,283	$165.95	$21,154	$246.86	$871.00 → NOBL
10	$21,870	$167.32	$22,884	$249.78	$1.0K → NOBL

ITCI vs NOBL: Complete Analysis 2026

ITCI — Stock

Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in developing lumateperone, which is in Phase III clinical trial for the treatment of bipolar depression, as well as to treat autism spectrum disorder; and in additional neuropsychiatric indications, such as sleep disorders associated with neuropsychiatric and neurological disorders. In addition, the company is developing Lenrispodun (ITI-214) for the treatment of Parkinson's disease and heart failure; ITI-1284-ODT-SL for the treatment of neuropsychiatric disorders and behavioral disturbances in dementia; and ITI-333 for substance use disorders, pain, and psychiatric comorbidities, including depression and anxiety. Intra-Cellular Therapies, Inc. was founded in 2002 and is headquartered in New York, New York.

Full ITCI Calculator →

NOBL — ETF

The fund will invest at least 80% of its total assets in component securities of the index. The index contains a minimum of 40 stocks, which are equally weighted, and no single sector is allowed to comprise more than 30% of the index weight. It seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction.

Full NOBL Calculator →

📬

Get this ITCI vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ITCI vs SCHD ITCI vs JEPI ITCI vs O ITCI vs KO ITCI vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.